CA-JUNIPER-NETWORKS
11.3.2024 20:26:32 CET | Business Wire | Press release
Juniper Networks (NYSE: JNPR), a leader in secure AI-Native Networking, today announced that Gartner, Inc. has named it a Leader in the 2024 Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure for the fourth time in a row. In the latest iteration of this Magic Quadrant, for the third time straight, Juniper is also positioned furthest in “Completeness of Vision,” a Gartner rating criterion that reflects innovation, and evaluates vendors on their ability to communicate that they understand client business issues in their target markets and have the products, services, vision and strategies to address these issues. In addition, Juniper was once again positioned highest for “Ability to Execute,” a Gartner rating criterion that evaluates vendors on their product/service, market responsiveness and customer experience.
As Gartner explains, “Magic Quadrants offer visual snapshots, in-depth analyses and actionable advice that provide insight into a market’s direction, maturity and participants. Assessing the market and its technology and service providers is a business-critical task. Vendor differentiation based on variations in operations, customer satisfaction, level of complexity and strategy can make comparisons of vendor offerings challenging. In addition, the market’s overall direction is often evolving. Gartner’s Magic Quadrants solve these problems by offering snapshots of markets and their participants, and help you map vendor strengths and cautions against your current and future needs.”
“We believe this latest recognition as a Leader by Gartner reinforces the value our products deliver for our customers,” said Sudheer Matta, Group Vice President, Products for the AI-Native Enterprise, Juniper Networks. “By delivering full-stack automation, insight and self-driving actions, Mist AI continues to stand out from the rest of the industry for fast deployments, the fewest tickets and quickest problem resolution. The momentum we are seeing is a true testament to our vision to design the industry’s first AI-Native Networking Platform from the ground up to provide reliable and consistent Wi-Fi experiences. By using automation to reduce or eliminate time-consuming manual tasks, and implementing automated workflows to proactively fix issues before they impact users, we consistently deliver proven value, saving substantial time and money for our customers and partners worldwide.”
In addition, Juniper recently announced record 2023 revenue results, marking the third consecutive year of business growth on a year-over-year basis. Juniper’s AI-Native enterprise solutions significantly outpaced the market, with revenue from wired and wireless access products attached to the Mist cloud growing nearly 70% on a full-year basis.
And as reported by the 650 Group Wireless LAN Infrastructure Quarterly Market & Long-Term Forecast Report 4Q23, published on March 1, 2024, while most of the industry contracted in Q4, Juniper continued its strong growth both Q/Q and Y/Y. In addition, Juniper was the fastest growing vendor on a full calendar year basis from 2022 to 2023.
Juniper solutions are deployed and helping drive better connections in 4 of the Fortune 10, 3 of the top-3 retailers, 2 of the top-5 Fintech companies, top Global universities, and the #1 healthcare provider in the United States. And Juniper’s public customer wins continue to expand across all verticals, with a host of new public success stories, including:
James Cook University Singapore
Juniper’s recognition in the Magic Quadrant for latest Enterprise Wired and Wireless LAN Infrastructure report is in addition to Gartner also recently naming Juniper Networks a Leader in the 2024 Gartner Magic Quadrant for Indoor Location Services for the third year in a row.
As the only vendor named a Leader in both the Wired and Wireless LAN Infrastructure and Indoor Location Services Magic Quadrant reports, Juniper believes its solutions are uniquely positioned to deliver exceptional experiences for both operators and end users. Automation in Juniper’s wired and wireless solutions not only helps accelerate deployments and eliminate up to 90% of networking-related trouble tickets, but our indoor location services offer customers and partners a scalable and cost-effective way to personalize wireless experiences with value-added features like wayfinding, asset location, and contextual notifications.
Additional Resources
- 2024 Gartner Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure: View Report
- Blog: Juniper’s Fourth Time in a Row: A Leader in the 2024 Gartner® Magic Quadrant™ for Enterprise Wired and Wireless LAN Infrastructure
- 2024 Gartner Magic Quadrant for Indoor Location Services: View Report
- Blog: Three Years in a Row: Juniper Networks® Once Again Named a Leader in the 2024 Gartner® Magic Quadrant™ for Indoor Location Services
- Juniper industry recognition: Learn more
Gartner Disclaimer
Gartner, Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure, Tim Zimmerman, Christian Canales, Nauman Raja, Mike Leibovitz 6 March 2024.
Gartner Magic Quadrant for Indoor Location Services, Global, Tim Zimmerman, Annette Zimmermann, et al., 28 February 2024.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Juniper Networks is recognized as Juniper in the 2024, 2022, and 2021 Magic Quadrant for Enterprise Wired and Wireless LAN Infrastructure reports.
About Juniper Networks
Juniper Networks believes that connectivity is not the same as experiencing a great connection. Juniper's AI-Native Networking Platform is built from the ground up to leverage AI to deliver the best and most secure user experiences from the edge to the data center and cloud. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on X (Twitter) LinkedIn and Facebook.
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240311703596/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom